Acasti Pharma - 12 Year Stock Price History | ACST
Historical daily share price chart and data for Acasti Pharma since 2012 adjusted for splits and dividends. The latest closing stock price for Acasti Pharma as of April 30, 2024 is 2.78.
- The all-time high Acasti Pharma stock closing price was 1953.60 on August 05, 2013.
- The Acasti Pharma 52-week high stock price is 3.84, which is 38.1% above the current share price.
- The Acasti Pharma 52-week low stock price is 1.72, which is 38.1% below the current share price.
- The average Acasti Pharma stock price for the last 52 weeks is 2.70.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Acasti Pharma Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2024 |
3.0064 |
2.7600 |
3.4500 |
2.1800 |
2.7800 |
-3.81% |
| 2023 |
2.8203 |
3.0162 |
4.8864 |
1.7700 |
2.8900 |
-3.86% |
| 2022 |
5.2597 |
8.2800 |
8.5800 |
2.0628 |
3.0060 |
-60.24% |
| 2021 |
21.7775 |
18.9600 |
57.6000 |
6.4200 |
7.5600 |
-51.54% |
| 2020 |
25.4259 |
114.2400 |
114.2400 |
8.7216 |
15.6000 |
-86.73% |
| 2019 |
71.5288 |
43.2000 |
139.2000 |
38.1600 |
117.6000 |
194.51% |
| 2018 |
39.7080 |
47.7600 |
75.3600 |
21.6921 |
39.9312 |
-11.76% |
| 2017 |
63.4118 |
61.7136 |
148.8000 |
45.2064 |
45.2544 |
-24.58% |
| 2016 |
71.7614 |
119.0400 |
134.8800 |
54.2400 |
60.0000 |
-50.98% |
| 2015 |
175.9656 |
242.7840 |
272.1600 |
76.8000 |
122.4000 |
-49.00% |
| 2014 |
448.7175 |
595.2000 |
676.8000 |
192.4800 |
240.0000 |
-60.00% |
| 2013 |
1166.4781 |
1032.0000 |
1953.6000 |
556.8000 |
600.0000 |
-41.86% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.026B |
$0.000B |
|
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
|
